Goodwin has added European patent attorney Colm Murphy as a partner in its London office. Murphy joins the firm to build its European patent prosecution practice, having moved from almost a decade as a partner at a previous firm. Mitch Bloom, chair of Goodwin’s Life Sciences practice, said: “Expanding our patent prosecution capabilities in Europe and the UK is key to growing our transatlantic life sciences IP capabilities and deepening our European patent expertise. “With Colm’s technical knowledge and proven track record in high-stakes patent matters in Europe, we can offer seamless cross-border IP services to our global clients navigating US and EU regulatory landscapes in high-growth markets,” he added. Murphy brings over 30 years of experience advising clients on IP matters in the biochemical, pharmaceutical, and medical device sectors. Commenting on the move, Murphy said: “By leveraging my experience in European patent strategy and complex EPO matters, I am looking forward to helping our clients navigate cross-border IP challenges and advance transformative innovations, particularly in the fast-growing venture and emerging companies space.”
Read the Life Sciences IP Review article for more.